Joint problems

Librela (for dogs) and Solensia (for cats) are two innovative and effective treatment options for osteoarthritis in our four-legged friends. ‍Librela contains bedinvetmab, a monoclonal antibody that targets Nerve Growth Factor (NGF). NGF plays a central role in the pain experience of osteoarthritis in dogs. By inhibiting NGF-mediated signaling, Librela can relieve pain related to the joint disease. Your veterinarian can prescribe Librela and guide you on dosage and use for your dog. ‍Solensia is a treatment for cats with osteoarthritis and contains frunevetmab, a feline-adapted monoclonal antibody that targets Nerve Growth Factor (NGF). Similar to dogs, Solensia can reduce pain related to osteoarthritis by inhibiting NGF-mediated signaling. This is particularly useful for cats that cannot be medicated with other medications due to kidney disease. Your veterinarian can advise on the best use of Solensia for your cat. ‍Both Librela and Solensia should be used according to your veterinarian's instructions and dosage. Before starting any new treatment for your pet, always consult your veterinarian to ensure that the product is appropriate for your animal's specific needs and health condition. By using these treatment options correctly, you can help reduce pain and improve the quality of life for your beloved cat and dog suffering from osteoarthritis.

See the section joint pain in our price list for prices